Financing: FONDECYT Regular 1201489
Acknowledgments: We gratefully acknowledge the financial support provided by the “Proyecto Puente” of Universidad Central de Chile.
Disclosure of conflict of interest: The author declare no conflict of interest.
Tiempo estimado de lectura: 3 min (338 palabras)
(Esta estimación no incluye el texto de las tablas, figuras y referencias)
Metabolic dysfunction-associated steatotic liver dis-ease (MASLD) is strongly associated with obesity, insulin resistance, chronic inflammation, and oxidative stress. Low dietary fiber intake contributes to gut microbiota dysbiosis, altered short-chain fatty acid (SCFA) production, and hepatic lipid accumulation. In this context, agroindustrial by-products from oilseed processing represent a sustainable source of functional ingredients with potential therapeutic value. This study aimed to evaluate the effects of fiberrich fractions obtained from partially defatted chia (Salvia hispanica L.) and basil (Ocimum basilicum L.) seeds on hepatic steatosis, insulin resistance, and associated metabolic disturbances in high-fat diet (HFD)-induced C57BL/6J male mice. Animals were fed either a control diet (CD) or HFD to induce metabolic dysfunction, followed by 4 weeks of supplementation with chia fiberrich fraction (FFC) or basil seed flour (BSF). Oatmeal supplementation was used as a physiological reference for soluble fiber functionality. Glycemia, insulinemia, HOMA-IR, lipid profile, inflammatory cytokines, oxidative stress markers, liver histology, hepatic lipid accumulation, SCFA production, and tissue fatty acid profiles were evaluated. Both FFC and BSF significantly reduced hepatic steatosis and improved metabolic parameters compared to HFD animals. BSF supplementation reduced HOMA-IR over 26%, decreased plasma triglycerides ~69%, and reduced TNF-α levels by more than 50%, while total SCFA production increased significantly, particularly acetic and butyric acids. FFC supplementation significantly reduced hepatic triglycerides to values comparable to the control diet, decreased LDL-cholesterol over 29%, and markedly improved liver histology by attenuating macrovesicular steatosis and reducing liver injury markers (AST, ALT, GGT). Both interventions increased tissue n-3 polyunsaturated fatty acids and improved hepatic metabolic homeostasis. These findings demonstrate that fiberrich fractions from chia and basil seeds are promising nutritional strategies for preventing hepatic steatosis and metabolic dysfunction, supporting the valorization of oilseed by-products as sustainable functional ingredients with translational potential for human metabolic health.
Keywords: MASLD, chia seed, basil seed
Financing: FONDECYT Regular 1201489
Acknowledgments: We gratefully acknowledge the financial support provided by the “Proyecto Puente” of Universidad Central de Chile.
Disclosure of conflict of interest: The author declare no conflict of interest.
Artículo anterior
Dieta baja en proteínas y marcadores de riesgo cardiovascular en pacientes con enfermedad renal crónica
Siguiente artículo
Huella proteómica de vesículas extracelulares derivadas de tejido adiposo como biomarcador de disfunción metabólica